Nov 30, 2020
WeissLaw LLP Reminds CCR, TCO, UROV, and PTI Shareholders About Its Ongoing Investigations
Nov 16, 2020
Proteostasis Therapeutics Reports Third Quarter 2020 Financial Results
Aug 06, 2020
Proteostasis Therapeutics Reports Second Quarter 2020 Financial Results
Jun 01, 2020
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19
May 15, 2020
Proteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 13, 2020
Proteostasis Therapeutics to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
Apr 13, 2020
Proteostasis Therapeutics Announces Completion of Scientific Advice Meeting with the Dutch Medicines Evaluation Board
Mar 10, 2020
Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
Feb 24, 2020
Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in Cystic Fibrosis
Jan 22, 2020
Proteostasis Therapeutics Announces Keystone Symposia Presentation of Organoid Study from More than 300 Adult CF Patients
Jan 13, 2020
Proteostasis Therapeutics Regulatory Update Following Scientific Advice Meeting with MHRA
Dec 17, 2019
Proteostasis Therapeutics Announces Positive Phase 2 Topline Results from Proprietary CFTR Modulator Combinations in F508del Homozygous Cystic Fibrosis Patients
Dec 11, 2019
Proteostasis Therapeutics to Initiate First Ever Personalized Medicine-Based Clinical Trial, CHOICES, in European CF Patients with Genotypes Ineligible for Approved CFTR Modulators
Dec 03, 2019
Proteostasis Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare Conference
Dec 02, 2019
Proteostasis Therapeutics Regains Compliance with Nasdaq Listing Standards
Nov 07, 2019
Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Nov 06, 2019
Proteostasis Therapeutics Announces Completion of Enrollment in Global Phase 2 Study in Cystic Fibrosis
Oct 24, 2019
Proteostasis Therapeutics Announces Presentations Highlighting its CFTR Modulators at the North American Cystic Fibrosis Conference
Oct 21, 2019
Proteostasis Therapeutics to Host Cystic Fibrosis Summit on Disparity in Access to CFTR Modulators Based on Geography Featuring Members of the Cystic Fibrosis Community and Thought Leaders
Sep 19, 2019
Proteostasis Therapeutics Announces Presentation at the UK Cystic Fibrosis Conference